Posts tagged BIIB


Biogen Inc (BIIB) Shares Slump as Spinraza US Sales Disappoint, But This Top Analyst Upbeat

Eric Schmidt views BIIB shares as undervalued based upon a stable MS franchise and Spinraza’s potential.

Read more

Let’s Hear It for Biogen Inc (BIIB) Drug Spinraza’s Blockbuster Potential, Raves Cowen Top Analyst

Coming off its successful launch of Spinraza, the first drug approved to treat children and …

Read more

Biotech Insights: Alcobra Ltd (ADHD), Biogen Inc (BIIB), Juno Therapeutics Inc (JUNO)

Alcobra Ltd  Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the …

Read more

Chardan Bullish on AveXis Inc (AVXS) Following Rival Spinraza Broad-Label Approval

Chardan analyst Gbola Amusa is placing his confidence behind AveXis Inc (NASDAQ:AVXS) even in light …

Read more

J. P. Morgan Analyst Sees Reason to Cheer Biogen Inc (BIIB) Following Early Approval of Drug Spinraza in SMA

J.P. Morgan analyst Cory Kasimov is out singing the praises of Biogen Inc (NASDAQ:BIIB) believing the FDA …

Read more

Cowen Skeptical on Biogen Inc (BIIB) Following Promotion of Chief Commercial Officer Michel Vounatsos to CEO

Biogen Inc (NASDAQ:BIIB) has decided to promote from within, opting to transition Chief Commercial Officer …

Read more

The Bears and the Bulls: Analysts Divided on Valeant Pharmaceuticals Intl Inc (VRX) and Biogen Inc (BIIB)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biogen Inc (NASDAQ:BIIB) have recently given biotech investors a …

Read more

Hendershot Investments Portfolio Review: Gilead Sciences, Inc. (GILD), Biogen Inc (BIIB)

As we reviewed our portfolio this quarter, we found ourselves in an unusual position…with nothing …

Read more

Analysts Chime in on Three Biotech Sector Players: Valeant Pharmaceuticals Intl Inc (VRX), Biogen Inc (BIIB), Eagle Pharmaceuticals Inc (EGRX)

Analysts are out with varied research reports on three of the biotech sector’s players: Valeant Pharmaceuticals …

Read more

H.C. Wainwright Weighs in on Biogen Inc (BIIB) Following World Muscle Society Congress

In a research report released today, H.C. Wainwright analyst Andrew Fein reiterated a Buy rating …

Read more